Corey's Pharma Hub

Tag: apixaban

DOACs in Renal Impairment: How to Adjust Dosing to Prevent Bleeding and Clots
  • Feb 9, 2026
  • Alyssa A
  • Pharmaceuticals
  • 14 Comments

DOACs in Renal Impairment: How to Adjust Dosing to Prevent Bleeding and Clots

DOACs like apixaban, rivaroxaban, and dabigatran require precise dosing adjustments in kidney disease to prevent bleeding or clots. Learn how to calculate creatinine clearance, which drugs are safest, and common mistakes to avoid.

Continue reading
Categories
  • Pharmaceuticals (119)
  • Health and Wellness (47)
  • General (1)
  • Legal and Compliance (1)
Latest posts
  • Nitrofurantoin and Hemolytic Anemia: What You Need to Know About G6PD Deficiency Risk
    Nitrofurantoin and Hemolytic Anemia: What You Need to Know About G6PD Deficiency Risk

    Jan 3, 2026

  • Cabergoline Safety Profile: Risks, Side Effects, and Monitoring Guide
    Cabergoline Safety Profile: Risks, Side Effects, and Monitoring Guide

    Oct 22, 2025

  • Asthma vs. COPD: Key Differences in Symptoms and Treatment
    Asthma vs. COPD: Key Differences in Symptoms and Treatment

    Feb 10, 2026

  • Warfarin and Generic Switching: What You Need to Know About INR Monitoring and Safety
    Warfarin and Generic Switching: What You Need to Know About INR Monitoring and Safety

    Nov 7, 2025

  • Generalized Anxiety Disorder: SSRIs, Benzodiazepines, and CBT Explained
    Generalized Anxiety Disorder: SSRIs, Benzodiazepines, and CBT Explained

    Feb 19, 2026

Popular tags
  • online pharmacy
  • drug interactions
  • medication safety
  • blood pressure
  • side effects
  • hypertension
  • heart health
  • warfarin
  • generic drugs
  • medication errors
  • NTI drugs
  • supplement interactions
  • anxiety medication
  • pain relief
  • herbal remedies
  • Cialis
  • affordable antidepressant
  • online pharmacy safety
  • asthma treatment
  • medication side effects

About

Pharmaceuticals

Menu

  • About Us
  • Terms
  • Privacy Policy
  • Data Protection Policies
  • Contact Us

© 2026. All rights reserved.